References
- Chase T. N., Ng L. K. Y., Watanabe A. M. Parkinson's disease. Modification by 5-hydroxytryptophan. Neurology 1972; 22: 479–484
- Gerson S. C, Baldessarini R. J. Motor effects of serotonin in the central nervous system. Life Sciences 1980; 27: 1435–1451
- Hallett M., Lindsey J. W., Adelstein B. D., Riley P. O. Controlled trial of isoniazid therapy for severe postural cerebellar tremor in multiple sclerosis. Neurology 1985; 35: 1374–1377
- Kozell L., Syndyk R., Wagner G. C., Fisher H. The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. Life Sciences 1987; 41: 1739–1744
- Meerwaldt J. D. Treatment of hypokinetic rigid syndrome with fluovoxamine maleate. Lancet 1986; 2: 977–978
- Pranzatelli M. R., Snodgrass S. R. The pharmacology of myoclonus. Clinical Neuropharmacology 1985; 8: 99–130
- Sandyk R. L-tryptophan in the treatment of restless legs syndrome. American Journal of Psychiatry 1986; 143: 554–555
- Sandyk R., Consroe P., Iacono R. P. L-tryptophan in drug-induced movement disorder with insomnia. New England Journal of Medicine 1986; 314: 1257
- Strahlendorf J. C., Hubbard G. D. Serotonergic interactions with rat cerebellar purkinje cells. Brain Research Bulletin 1983; 11: 265–269